AutoICD API

75411-9

Laboratory

Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection

Definition

The Ebola Zaire PCR assay presumptively detects Ebola Zaire virus, a single-stranded RNA virus identified in the 2014 West Africa outbreak. The assay is used for testing individuals with signs and symptoms of Ebola virus infection, those who are at risk for or may have been exposed to the Ebola Zaire virus, or in accordance with current public health recommendations. The definitive identification of the Ebola Zaire virus requires additional testing and confirmation procedures in consultation with public health. This term was developed for, but is not limited to, use with the Ebola Zaire Target 1 (EZ1) real-time reverse transcription (rRT) polymerase chain reaction (TaqMan®) assay (EZ1 assay), which is run on plasma or whole blood specimens. As of August 2014, the EZ1 assay is approved for use under an FDA Emergency Use Authorization (EUA) [http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM408334.pdf] by specified laboratories and clinical laboratory personnel who have been trained on instruments authorized by the U.S. Department of Defense.

LOINC 6-Axis Classification

Component

Ebola Zaire virus RNA

Property

PrThr

Time Aspect

Pt

System

Plas/Bld

Scale Type

Ord

Method Type

Probe.amp.tar

Details

Class

MICRO

Order/Observation

Both

Short Name

EZ1 RNA PlasBld Ql NAA+probe

Display Name

Ebola Zaire virus RNA NAA+probe Ql (P/Bld)

Related Names

3 Self-Sustaining Sequence Replication3SR SRAmplifAmplificationAmplifiedBloodDNA NUCLEIC ACID PROBEDNA probeEZ1EZ1 RNAIDInfectious DiseaseInfectiousDiseaseLATLCRLigase chain reactionLigation-activated transcriptionMicrobiologyNAA+probeNAATNASBANucleic acid sequence based analysisOrdinalPCRPlPlasBldPlasmaPlsmPoint in timePolymerase chain reactionPRProbe ampProbe with ampificationProbe with target amplificationQBRQLQualQualitativeRandomRibonucleic acidScreenSDAStrand Displacement AmplificationTMATranscription mediated amplificationWBWhole blood

Frequently Asked Questions

What is LOINC code 75411-9?

LOINC code 75411-9 identifies "Ebola Zaire virus RNA [Presence] in Plasma or Blood by NAA with probe detection". The Ebola Zaire PCR assay presumptively detects Ebola Zaire virus, a single-stranded RNA virus identified in the 2014 West Africa outbreak. The assay is used for testing individuals with signs and symptoms of Ebola virus infection, those who are at risk for or may have been exposed to the Ebola Zaire virus, or in accordance with current public health recommendations. The definitive identification of the Ebola Zaire virus requires additional testing and confirmation procedures in consultation with public health. This term was developed for, but is not limited to, use with the Ebola Zaire Target 1 (EZ1) real-time reverse transcription (rRT) polymerase chain reaction (TaqMan®) assay (EZ1 assay), which is run on plasma or whole blood specimens. As of August 2014, the EZ1 assay is approved for use under an FDA Emergency Use Authorization (EUA) [http://www.fda.gov/downloads/MedicalDevices/Safety/EmergencySituations/UCM408334.pdf] by specified laboratories and clinical laboratory personnel who have been trained on instruments authorized by the U.S. Department of Defense.

What does 75411-9 measure?

This code measures Ebola Zaire virus RNA in Plas/Bld. It belongs to the MICRO class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.